Clinical trial
Response to Influenza Vaccination in Lymphoma Patients Treated With CHOP and Rituximab
NCT01707628 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Response to Influenza Vaccination in Lymphoma Patients Treated With CHOP and Rituximab
- Lead sponsor
- St. Antonius Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- June 30, 2013
- Enrollment
- 98 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
non-hodgkin lymphoma (nhl)